MIST
Milestone Pharmaceuticals Inc
0.8097$
-0.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | |
| – | – | – | 2.5% | – | 9.6% | 59.8% | – | 7.4% | |
| – | – | – | -2.5% | 100.0% | 100.0% | 100.0% | – | 92.6% | |
| – | – | – | 232.4% | 257.8% | 796.6% | 3,105.2% | – | 1,171.3% | |
| – | – | – | 66.4% | 82.7% | 314.4% | 1,593.2% | – | 1,117.3% | |
| – | – | – | 338.1% | 387.2% | 1,292.8% | 6,209.8% | – | 4,134.3% | |
| – | – | – | -338.1% | -287.2% | -1,192.8% | -6,109.8% | – | -4,041.7% | |
| – | – | – | 4.8% | 1.5% | 25.1% | 255.4% | – | 248.3% | |
| – | – | – | -333.2% | -285.7% | -1,167.8% | -5,968.5% | – | -4,101.1% | |
| – | – | – | -0.1% | -1.5% | -25.1% | -31.2% | – | -22.3% | |
| – | – | – | -333.1% | -285.7% | -1,142.7% | -5,968.5% | – | -4,078.8% | |
| – | – | – | -337.4% | -285.1% | -1,191.1% | -5,703.9% | – | -3,845.5% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.